Mesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trials.

Patchett, Amanda L; Tovar, Cesar; Blackburn, Nicholas B; Woods, Gregory M; Lyons, A Bruce

Patchett, Amanda L; Tovar, Cesar; Blackburn, Nicholas B; Woods, Gregory M; Lyons, A Bruce.

Afiliación

Patchett AL; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Tovar C; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Blackburn NB; School of Medicine, University of Tasmania, Hobart, TAS, Australia.
Woods GM; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Lyons AB; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.

Immunol Cell Biol ; 99(7): 711-723, 2021 08.

Article en En | MEDLINE | ID: mdl-33667023

Asunto(s)

Neoplasias Faciales; Marsupiales; Vacunas; Animales; Neoplasias Faciales/terapia; Humanos; Inmunoterapia; Vacunación

Palabras clave

Devil Facial Tumour Disease; Tasmanian devil; cancer vaccine; epithelial-to-mesenchymal transition; mesenchymal plasticity; transmissible cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Faciales / Vacunas / Marsupiales Límite: Animals / Humans Idioma: En Revista: Immunol Cell Biol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google